- Research
- Open Access
- Published:

# Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest

*BMC Bioinformatics*
**volume 23**, Article number: 547 (2022)

## Abstract

As of June 2022, the GISAID database contains more than 11 million SARS-CoV-2 genomes, including several thousand nucleotide sequences for the most common variants such as delta or omicron. These SARS-CoV-2 strains have been collected from patients around the world since the beginning of the pandemic. We start by assessing the similarity of all pairs of nucleotide sequences using the Jaccard index and principal component analysis. As shown previously in the literature, an unsupervised cluster analysis applied to the SARS-CoV-2 genomes results in clusters of sequences according to certain characteristics such as their strain or their clade. Importantly, we observe that nucleotide sequences of common variants are often outliers in clusters of sequences stemming from variants identified earlier on during the pandemic. Motivated by this finding, we are interested in applying outlier detection to nucleotide sequences. We demonstrate that nucleotide sequences of common variants (such as alpha, delta, or omicron) can be identified solely based on a statistical outlier criterion. We argue that outlier detection might be a useful surveillance tool to identify emerging variants in real time as the pandemic progresses.

## Introduction

More than 13 million nucleotide sequences of the SARS-CoV-2 virus have been collected from patients around the world since the beginning of the pandemic and made available in the GISAID database [1, 2]. Among them are thousands of nucleotide sequences of the most common variants, precisely for the alpha (B.1.1.7), beta (B.1.351), delta (B.1.617.2), gamma (P.1), GH (B.1.640), lambda (C.37), mu (B.1.621), and omicron (B.1.1.529) variants [3].

The emergence of new variants of the SARS-CoV-2 virus poses a threat to the progress made by ongoing vaccination campaigns against COVID-19. Therefore, the detection and possible identification of newly emerging variants of the SARS-CoV-2 virus in (close to) real time is of great interest.

Currently, a tool called “genomic surveillance” is used by the Centers for Disease Control (CDC) to detect new variants [4]. This is done both through the National SARS-CoV-2 Strain Surveillance (NS3) program, as well as through commercial and academic laboratories contracted by the CDC, where genetic information of SARS-CoV-2 specimen are analyzed and classified into variants. By definition, a variant is characterized by having one or more mutations which differentiate it from other variants of the SARS-CoV-2 virus [5]. A group of variants with similar genetic changes (a lineage) can be classified as a variant of concern (VOC) or a variant of interest (VOI) if they share characteristics that potentially necessitate public health action. For example, the U.S. government SARS-CoV-2 Interagency Group (SIG) classified omicron as a Variant of Concern (VOC) on 30 November 2021 due to the fact that omicron emerged in multiple countries without apparent travel history, the replacement of certain delta variants as predominant variants in South Africa by omicron, and its number of mutations in the spike protein which indicated a reduced susceptibility to sera from vaccinated individuals and certain monoclonal antibody treatments. The purpose of this article is to explore the ability of new unsupervised learning methodology to detect emerging variants of interest.

As shown previously in the literature [6, 7], an unsupervised cluster analysis in which the similarity of all pairs of nucleotide sequences is assessed using the Jaccard index, and subsequent application of principal component analysis to the Jaccard similarity matrix, results in clusters of sequences according to certain characteristics such as their strain or their clade. Importantly, in [8] the authors notice that nucleotide sequences the omicron variant cluster among sequences stemming from variants identified earlier on during the pandemic. Due to the fact that the aforementioned unsupervised approaches successfully clustered nucleotide sequences by strain or clade, and revealed features of the omicron variant, we likewise focus on an unsupervised approach based on the Jaccard similarity matrix in connection with principal component analysis in this work.

This finding immediately prompts the question whether the nucleotide sequences belonging to common variants can be identified by unsupervised outlier detection. In this article, we investigate this question by applying outlier detection to nucleotide sequences, both before the emergence of a variant and after a variant has emerged. We demonstrate that indeed, the number of detected outliers often increases shortly after the emergence of a new variant, and that nucleotide sequences of common variants can be identified solely based on a statistical outlier criterion.

Our findings could have important implications for the automated, unsupervised identifications of SARS-CoV-2 strains. We argue that outlier detection might be a useful surveillance tool to identify emerging variants of interest in real time as the pandemic progresses. This is also important for vaccination strategies, to identify emerging variants that may be resistant to available vaccines [9].

The article is structured as follows. The “Methods” section introduces the methodology we use for this article, starting with data acquisition and cleaning, and how the similarity of sequences is assessed. We then describe the outlier detection method we use. The “Results” section presents our findings on the clustering and outlier detection of SARS-CoV-2 nucleotide sequences. The article concludes with a “Discussion” section.

## Methods

In this section, we highlight methodological features of the analysis. In particular, we describe data acquisition and cleaning (“Data acquisition and cleaning” section), the assessment of the similarity of nucleotide sequences (“Assessing the similarity of nucleotide sequences” section), the methods used for outlier detection among sequences (“Outlier detection” section), and the calibration of the outlier detection (“Calibration” section).

### Data acquisition and cleaning

All findings reported in this article are based on an image of all available SARS-CoV-2 nucleotide sequences in the GISAID database [1, 2] until 28 March 2022, consisting of 211,167 sequences having accession numbers in the range of EPI_ISL_403962–EPI_ISL_11498019. By timestamp we always refer to the collection date on GISAID. Sequences are only included in the analysis if they satisfy the four data quality attributes on GISAID. To be precise, all nucleotide sequences have to satisfy the criterion of being *complete* (defined as sequences having length at least 29,000 bp), *high coverage* (defined as sequences with less than 1% N-bases), *with patient status* (defined as sequences with meta information consisting of age, sex, and patient status), and *collection date complete* (defined as sequences with a complete year-month-day collection date) (Additional file 1).

We aim to investigate if it is possible to detect sequences of a new variant among the other sequences in circulation upon emergence of that new variant. We consider eight common SARS-CoV-2 variants available on GISAID. Those are alpha (B.1.1.7), beta (B.1.351), delta (B.1.617.2), gamma (P.1), GH (B.1.640), lambda (C.37), mu (B.1.621), and omicron (B.1.1.529) variants (Table 1).

To detect a new variant, we generate two reference datasets for each variant. For the first dataset, we determine the timepoint T_{1} at which the first sequences of each variant under consideration emerge on GISAID. We then generate the first reference dataset using only sequences from GISAID with a timestamp before T_{1}. The second dataset emulates the emergence of a new variant. For this we determine the timepoint T_{2} at which 10% of all the sequences of a variant under consideration are available on GISAID (the threshold of 10% is arbitrary). We then generate the second reference dataset using only sequences from GISAID with a timestamp up to T_{2}. The details of the reference dataset up to T_{1} are given in Table 2, the sequences we aim to detect for each variant are given in Table 3, and the combined dataset simulating the emergence of each variant up to timepoint T_{2} is given in Table 4. As before, the timestamps T_{1} and T_{2} mentioned in the article and in Tables 2, 3 and 4 refer to the collection date on GISAID.

Our planned subsequent computations on the nucleotide sequences (the calculation of the principal components of the Jaccard similarity matrix) are too computationally intensive to be carried out for all available sequences on GISAID. For this reason, we down-sample each dataset by drawing an unbiased sample of size 10,000 without replacement.

Using the alignment tool MAFFT [10] and the official SARS-CoV-2 reference sequence (available on GISAID under the accession number EPI_ISL_402124), we align all n sequences to the reference genome. We employed MAFFT with the *keeplength* option in order to obtain a well-defined window (of length L = 29,891 base pairs) for comparison of all sequences. All other parameters of MAFFT were kept at their default values.

### Assessing the similarity of nucleotide sequences

We next convert all sequences into a binary Hamming matrix X ∈ B^{n x L} (where B = {0,1} is the set of binary numbers) as follows. We compare the reference genome to each aligned nucleotide sequence, and set X_{ij} = 1 if the sequence with number i differs at position j from the reference sequence. Otherwise, we set X_{ij} = 0. Here, the number of rows of X is set to the number of nucleotide sequences, and L = 29,891 is the number of base pairs in the comparison window. The row sums of X correspond to the Hamming distance of each nucleotide sequence to the reference genome. This methodology has already been used in the literature [6,7,8, 11].

We employ the Jaccard similarity measure [12,13,14] to assess the similarity of all pairs of sequences. To be precise, each entry (i,j) of the Jaccard matrix J(X) ∈ ℝ^{n x n} (having n rows and n columns) is a measure of similarity between the binary rows i and j of X. An entry (i,j) of J(X) of zero encodes that the two genomes do not share any deviations from the reference genome, while an entry of one encodes equality of rows i and j of X. We employ the R-package “locStra”, available on CRAN [15, 16], to compute the Jaccard matrix.

For all figures included in this work, we visualize the Jaccard similarity measures by computing its first two principal components. We plot the first principal component against the second principal component, thus effectively interpreting the entries of the first eigenvector as x-coordinates, and the ones of the second eigenvector as y-coordinates. We color each point according to either a time stamp, according to its cluster membership, or according to whether it is an outlier.

### Outlier detection

We are interested in detecting sequences falling into neighborhoods or clusters in which they are classified as outliers (subject to a certain criterion). To be precise, we are interested in sequences falling into neighborhoods consisting of sequences having much older (or newer) time stamps.

We aim to utilize an approach which is not dependent on previously identified clusters. One way to achieve this is to define a local environment of radius eps > 0 around each sequence in a principal component plot (each sequence corresponds to a point in the principal component plot), and to consider all other (that is, similar) sequences falling into that local environment. Comparing the time stamp of the sequence under consideration to the distribution of timestamp in the local environment allows one to define an outlier. We say that a sequence is an outlier in its local environment if its time stamp is more than f > 0 standard deviations from the mean date in the environment.

### Calibration

Our clustering approach depends on two tuning parameters, the radius of the local environment eps, and the factor f that specifies how many standard deviations away from the mean date are needed to define a sequence as an outlier. To calibrate both parameters, we look at the number of outliers which are identified in the data as a function of both eps and f. This results in a typical “elbow” plot, though here in two dimensions (see Fig. 2). For small values of f, meaning values close to the mean, many outliers are flagged. As f increases, fewer and fewer outliers are identified. The decrease is usually not linear. Instead, the number of outliers usually drops rapidly at a certain cutoff f before leveling off, thus giving the plot its name. The point at which the plot levels off can be used to determine f. We apply the elbow method to both set the parameter f, as well as the parameter eps.

## Results

We first focus on the newest variant, omicron. Figure 1 shows a plot of the first two principal components of the Jaccard matrix as outlined in section “Assessing the similarity of nucleotide sequences”. As observed previously [8] the genomes from GISAID exhibit a particular progression pattern, with older sequences (green) clustering in the middle of the plot, while newer samples (red) cluster at the bottom of the plot. The progression of genomes seems to take place from the early point cloud (green, middle), to genomes with intermediate timestamps (top), to new samples (red, bottom). As also observed in the aforementioned publication, genomes of the omicron strain are most similar to genomes in stemming from early on in the pandemic. This is visible from Fig. 1 as omicron samples (triangles) fall into a point cloud of early (green) genomes.

Interestingly, the observations for Fig. 1 are virtually identical with the ones made in [8], even though both experiments are made with independent, and thus entirely different, subsamples without replacement of size 10,000 taken from all complete sequences available on GISAID.

Before applying the approach of “Outlier detection” section, we calibrate the outlier detection on the omicron data as outlined in section “Calibration”. Figure 2 shows the two dimensional elbow plot of the number of flagged outliers as a function of both the radius of the local environment eps and the parameter f. We indeed observe a distinct shape of the decrease in the number of outliers as the parameter f increases, with a sharp decrease at around f = 1.2, after which the plot levels off. Interestingly, the algorithm is rather insensitive to the choice of the local environment eps, apart from the case eps = 0. We repeated the calibration for the other variants as well. Interestingly, the parameters f = 1.2 and eps = 1e-1 emerge as consistent choices for all variants. Therefore, we use f = 1.2 and eps = 1e-1 in the remainder of the section.

After calibration, we aim to identify outliers using the local detection approach of “Outlier detection” section. Figure 3 shows the same principal components as Fig. 1 for the omicron variant, though this time without any coloring by timestamp. Instead, all points in yellow have the property that they pass the local outlier criterion of “Outlier detection” section, meaning that they are outliers in a local epsilon environment centered around them, subject to the calibration of “Calibration” section.

Interestingly, using the same calibration, a number of other sequences not belonging to the omicron strain are flagged in Fig. 3. These belong to the delta variant of the SARS-CoV-2 virus. In what way these samples differ from the other delta variant samples in Fig. 3 remains an important question of future work.

Next, we investigate the behavior of the outlier detection upon the emergence of a new variant. We are especially interested if an increase in outliers can be detected upon the emergence of a new variant. To this end, for each variant under investigation (alpha, beta, delta, gamma, GH, lambda, mu, omicron), we apply the same calibrated outlier detected to first the reference dataset before the emergence of each variant, and after the emergence of each variant. Figures 4, 5, 6, 7, 8, 9, 10 and 11 show results for all eight variants (alpha, beta, delta, gamma, GH, lambda, mu, omicron). The left column always corresponds to the time period before the emergence of each variant, and the right column corresponds to the time period after the emergence of each variant. The top plots show the first two principal components with highlighted sequences for each variant under consideration, the bottom plots show the local outliers as yellow triangles. We observe that for the beta, delta, GH, and omicron variants the number of detected outliers considerably increases after the emergence of the variant. For the other variants, the change in the number of outliers is less pronounced. For the gamma variant, the number of detected outliers considerably decreases after the emergence of the variant.

To concretize results, Table 1 summarizes the total number of detected outliers, the number of detected genomes per variant, and the number of genomes for each variant that is included in the dataset (and that can possibly be detected). We observe that for the common variants beta, delta, GH, and omicron, the detection of the emergence of a new strain is possible. Clearly the biological importance of a new variant cannot be assessed via outlier detection, but the proposed method would have been able to flag these strains as variants of interest.

Interestingly, Table 1 shows that the number of outliers before emergence of a variant varies widely among variants. This is due to the fact that the reference datasets are independently subsampled from GISAID in order to match the timepoint T_{1} at which each variant occurs first. With our results we aim to demonstrate that a surge in outliers can happen upon emergence of a variant, meaning that the (relative) difference in the number of outliers is of interest and could be indicative of a change in the dynamics of the pandemic.

It is noteworthy to point out that in the case of Fig. 10, the plot of the first two principal components changes before and after the emergence of a variant. This is attributed to how eigenvectors (principal components) change when perturbing a matrix (for instance, [17] provides a bound on the angle of the perturbed eigenvector). Therefore, adding more data from GISAID to the computation of the Hamming matrix and the subsequent computation of the Jaccard matrix can change the Jaccard matrix and its eigenvectors.

Finally, we also consider a control case in which no new variant occurs. Figure 12 shows an example of this scenario using the alpha variant. To prepare Fig. 12, we divided the reference dataset for the alpha variant (see Table 2) into two parts. The first contains the first 5000 sequences in sorted order of their timestamps, while the second part contains the later 5000 sequences. As before, we observe a certain number of outliers in the first dataset (Fig. 12, bottom left). In contrast to the other figures, sequences highlighted in Fig. 12 (bottom left) are not highlighted again in Fig. 12 (bottom right), confirming in this example that a surge would not be detected at this point in time.

## Discussion

In this work, we demonstrate that nucleotide sequences of common virus strains/variants can be identified solely based on a statistical outlier criterion in real time. To this end, we prepare two reference datasets, one before and one after the emergence of eight common SARS-CoV-2 variants (alpha, beta, delta, gamma, GH, lambda, mu, omicron) available on the GISAID database, and apply an outlier detection method to those datasets.

Using the proposed local outlier detection approach, we can identify genomes belonging to the beta, delta, GH, and omicron strain upon emergence of these variants. However, this detection comes at the cost of a larger number of false positives. The nature of those other nucleotide sequences that pass our outlier criteria, and in what way they differ from other sequences of the most common SARS-CoV-2 variants, is an important direction of ongoing research.

The large number of false positives we observe when applying outlier detection to nucleotide sequences can pose a problem for the task of accurately highlighting newly emerging sequences. The primary aim of this proposed methodology is for use as an online screening tool, or warning system, to detect the emergence of a new variant through an increase in outliers. Additional work would be required to confirm which outliers are newly emerging variants of concern.

In our study we aim to demonstrate the usefulness of the proposed methodology for prediction. However, not all mathematical models are useful prediction tools. Various prediction models have been proposed since the start of the pandemic, with various success. For instance, some models forecasted that SARS-CoV-2 would not develop any variants with distinct pathologies [18], while others concluded based on hidden Markov models that certain variants with deleterious mutations go extinct [19]. A comprehensive and retrospect assessment of the accuracy of (non-pharmacological intervention) models for the case of Sweden can be found in [20], where the authors conclude that some models significantly overestimated the virus spread.

Importantly, this research shows that outlier detection might be a useful tool to identify emerging variants in real time as the pandemic progresses, using machine learning techniques and purely statistical methods only.

An important direction of further work addresses the question of whether certain sites/loci on the SARS-CoV-2 genome are more predictive for a certain outcome than others. For instance, certain high frequency (hot spot) mutation sites are known for the coronavirus family which result in different pathologies, such as seen in the MERS-CoV nsp3 protein [21]. Similarly, future work could look into the more stable low frequency (cold spot) mutation sites, since those potentially allow for a more robust characterization of strains or new variants.

## Availability of data and materials

The data that support the findings of this study are publicly available in the GISAID database [1, 2], see https://gisaid.org/. Additionally, the supplementary material of this manuscript contains, for each variant under consideration (alpha, beta, delta, gamma, GH, lambda, mu, omicron), lists of IDs for the two reference datasets (simulating the time before the emergence of a new variant and the onset of a new variant).

## References

Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Global Chall. 2017;1:33–46.

Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data—from vision to reality. EuroSurveillance. 2017;22(13):30494.

UCSC Genome Browser on SARS-CoV-2 (2022). Omicron variant: https://genome.ucsc.edu/cgi-bin/hgTracks?hgsid=1237196085_IsfCVVz6HLtTQ0q0pmGkwwWhAaWH&db=wuhCor1&position=lastDbPos.

Centers for Disease Control and Prevention. Monitoring variant proportions. 2022. https://covid.cdc.gov/covid-data-tracker/#variant-proportions.

Centers for Disease Control and Prevention. SARS-CoV-2 variant classifications and definitions. 2022. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html.

Hahn G, Lee S, Weiss ST, Lange C. Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus. Genet Epidemiol. 2020;45(3):316–23.

Hahn G, Lee S, Weiss ST, Lange C. Unsupervised cluster analysis of SARS-CoV-2 genomes indicates that recent (June 2020) cases in Beijing are from a genetic subgroup that consists of mostly European and South(east) Asian samples, of which the latter are the most recent. BioRxiv Method. 2020. https://doi.org/10.1101/2020.06.22.165936.

Hahn G, Lee S, Prokopenko D, Novak T, Hecker J, Khurana S, Baden L, Randolph A, Weiss S, Lange C. Unsupervised genome-wide cluster analysis: nucleotide sequences of the Omicron variant of SARS-CoV-2 are similar to sequences from early 2020. BioRxiv. 2022. https://doi.org/10.1101/2021.12.29.474469.

Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, Cantoni D, Scott S, Logan N, Ashraf S, Manali M, Szemiel A, Cowton V, Vink E, Harvey WT, Davis C, Asamaphan P, Smollett K, Tong L, Orton R, Hughes J, Holland P, Silva V, Pascall DJ, Puxty K, da Silva FA, Yebra G, Shaaban S, Holden MTG, Pinto RM, Gunson R, Templeton K, Murcia PR, Patel AH, Klenerman P, Dunachie S, PITCH Consortium, COVID-19 Genomics UK (COG-UK) Consortium, Haughney J, Robertson DL, Palmarini M, Ray S, Thomson EC. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022;7(8):1161–79.

Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002;30(14):3059–66.

Hahn G, Wu C, Lee S, Lutz S, Khurana S, Baden L, Haneuse S, Qiao D, Hecker J, DeMeo D, Tanzi R, Choudhary M, Etemad B, Mohammadi A, Esmaeilzadeh E, Cho M, Li J, Randolph A, Laird N, Weiss S, Silverman E, Ribbeck K, Lange C. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain. Genet Epidemiol. 2021;45(7):685–93.

Jaccard P. Étude comparative de la distribution florale dans une portion des Alpes et des Jura. Bull Soc Vaud Des Sci Nat. 1901;37:547–79.

Prokopenko D, Hecker J, Silverman E, Pagano M, Nöthen M, Dina C, Lange C, Fier H. Utilizing the Jaccard index to reveal population stratification in sequencing data: a simulation study and an application to the 1000 genomes project. Bioinformatics. 2016;32(9):1366–72.

Schlauch D, Fier H, Lange C. Identification of genetic outliers due to sub-structure and cryptic relationships. Bioinformatics. 2017;33(13):1972–9.

Hahn G, Lutz SM, Hecker J, Prokopenko D, Cho MH, Silverman E, Weiss ST, Lange C. locstra: Fast analysis of regional/global stratification in whole genome sequencing (wgs) studies. Genet Epidemiol. 2020;45(1):82–98.

Hahn G, Lutz SM, Lange C. locStra: fast implementation of (Local) population stratification methods (v1.3). 2020. https://cran.r-project.org/package=locStra.

Davis C, Kahan WM. The rotation of eigenvectors by a perturbation. III. SIAM J Numer Anal. 1970;7:1–46.

MacLean OA, Orton RJ, Singer JB, Robertson DL. No evidence for distinct types in the evolution of SARS-CoV-2. Virus Evol. 2020;6(1):veaa034.

Schiøler H, Knudsen T, Brøndum RF, Stoustrup J, Bøgsted M. Mathematical modeling of SARS-CoV-2 variant outbreaks reveals their probability of extinction. Sci Rep. 2021;11:24498.

Carlsson M, Söderberg-Nauclér C. COVID-19 modeling outcome versus reality in Sweden. Viruses. 2022;14(8):1840.

Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol. 2017;25(1):35–48.

## Funding

Funding for this research was provided through the National Institutes of Health (1R01AI154470-01; 2U01HG008685; R01HG008976; U01HL089856, U01HL089897, P01HL120839, P01HL132825, 2U01HG008685), and the National Science Foundation (NSFPHY 2033046 and NSF GRFP 1745302), and NIH Center Grant P30-ES002109.

## Author information

### Authors and Affiliations

### Contributions

GH conducted all experiments and wrote the manuscript. SL, DP, JA, TN, JH, MC, SK, LB, AR, SW, and CL gave technical advice and reviewed the manuscript. All authors read and approved the final version of the manuscript.

### Corresponding author

## Ethics declarations

### Ethics approval and consent to participate

Not applicable.

### Consent for publication

Not applicable.

### Competing interests

The authors declare that they have no competing interests.

## Additional information

### Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## Supplementary Information

**Additional file 1.**

Lists of GISAID IDs for the two reference datasets (simulating the time before the emergence of a new variant and the onset of a new variant) for each variant under consideration in the article (alpha, beta, delta, gamma, GH, lambda, mu, omicron).

## Rights and permissions

**Open Access** This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

## About this article

### Cite this article

Hahn, G., Lee, S., Prokopenko, D. *et al.* Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest.
*BMC Bioinformatics* **23**, 547 (2022). https://doi.org/10.1186/s12859-022-05105-y

Received:

Accepted:

Published:

DOI: https://doi.org/10.1186/s12859-022-05105-y

### Keywords

- SARS-CoV-2
- Nucleotide sequences
- Outlier detection
- Variants of interest
- Machine learning